# MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

> **NCT05937594** · — · RECRUITING · sponsor: **Milton S. Hershey Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome

## Interventions

- **GENETIC:** Buccal swab saliva for further genetic testing

## Key facts

- **NCT ID:** NCT05937594
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-15
- **Primary completion:** 2026-12-10
- **Final completion:** 2027-04-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937594, "MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05937594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*